To evaluate the clinical relevance of Rab1B and MMP9 protein expression in CRC patients, the median IHC scores of 180 and 156 were defined as the cutoff value for high- and low-expression of Rab1B and MMP9, respectively, which divided CRC patients into high- or low-expression groups. The gene discussed is MMP9; the disease is colorectal carcinoma.